A paper in PNAS this week reporting that a signature of microRNA (miRNA) gene expression correlates with diagnosis and prognosis of B-cell chronic lymphocytic leukemias (CLLs) has drawn skepticism ...

SANTA CLARA, Calif.-Agilent Technologies Inc. (NYSE: A), today announced the release of eArray 5.4 online microarray design tool, which enables users to design custom microRNA (miRNA) microarrays.

Life Science Firms are Scampering to Enter Market to Take Advantage of Research Trend The discovery that miRNA plays a pivotal role in the regulation of gene expression sparked tremendous interest ...

The Geniom® RT Analyzer, a new benchtop microarray processing instrument, was presented by febit at Select Bioscience’s “Advances in Microarray Technology”. The platform complements Geniom® One, the ...

Agilent Technologies, Inc., and Cogenics, a division of Clinical Data, Inc. have announced that Cogenics is the first Certified Microarray Service Provider for Agilent’s microRNA (miRNA) microarrays.

Rare incidence of congestive heart failure (CHF) in gastrointestinal stromal tumor (GIST) and other sarcoma patients (pts) receiving imatinib mesylate (IM) therapy No significant financial ...

The detection of cancer-associated micro-ribonucleic acids (miRNAs) in urine through a combination of nanowire-based miRNA extraction and machine learning (ML) analysis can fuel the development of ...

A. miRNA and circulating miRNA in extracellular vesicles can be obtained from cancer tissues and blood samples. B. miRNA detection is characterized by stability, specific expression, and low trauma. C ...